Unveiling quality, clinical, and financial Impacts of Pulmonary Tuberculosis Clinical Pathway Implementation in Magelang Public Hospital, Indonesia 10.55131/jphd/2024/220120
Article Sidebar
Main Article Content
Abstract
Tuberculosis (TB) is a popular endemic disease in Indonesia with increased risk outcomes. The clinical pathway (CP) is crucial to enhancing healthcare services and resource efficiency despite discrepancies in service variability reduction, clinical outcomes improvement, and cost saving. Therefore, this study aimed to assess pulmonary TB CP and evaluate its impacts on clinical and financial results, as well as barriers to implementation at Tidar Hospital in Magelang, Indonesia. A sequential explanatory mixed-method design was used from July 2022 to January 2023. The study began with a retrospective analysis of medical records of TB patients (total sampling, n=92). In-depth interviews (IDIs) were conducted with healthcare workers including the quality and medical committee, case manager, CP team, inpatient and non-inpatient nursing sub-coordinators, and pulmonary specialists. In addition, eight multidiscipline healthcare professionals attended the focus group discussions (FGDs). The audio recordings were transcripted verbatim and subjected to thematic analysis. The results showed that the quality and content of CP based on TB evaluation using the Integrated Clinical Pathway Assessment Tool (ICPAT) was 62.6%. Four themes were obtained: 1) CP implementation techniques, 2) supportive factors in the success of CP, 3) organization support in CP implementation, and 4) TB patient outcomes. Furthermore, procedure compliance after CP implementation was 33%. There were no significant differences in the length of stay (p=0.77), diagnosis investigation and therapy appropriateness (100%), mortality (4 vs 3 patients; p=0.589), and cost efficiency with an average cost of care (Rp 6.994.508,- vs Rp 5.521.091,-; p=0.083) before and after CP implementation. Readmission rates were low before and after deployment (1 vs. 2 patients). This study found no significant clinical or financial benefits in TB CP implementation. These results imply the need for hospital leadership and a multidisciplinary team to overcome CP implementation hurdles.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
World Health Organization. WHO consolidated guidelines on tuberculosis. WHO Press. 2022. p. 98.
Kemenkes RI. pedoman SUN. Pedoman Nas Pelayanan Kedokt Tata Laksana Tuberkulosis. 2013;i–100.
World Health Organization. Global Tuberculosis Report 2022 [Internet]. 2022. Available from: http://journal. um-surabaya.ac.id/index.php/JKM/ article/view/2203
Siswanto M, Chalidyanto D. Impact of Clinical Pathways Compliance for Reducing Length of Stay. J Adm Kesehat Indones. 2020;8(1):79.
Kemenkes. Peraturan Menteri Kesehatan Republik Indonesia Nomor 12 Tahun 2020 Tentang Akreditasi Rumah Sakit [Internet]. 2020. Available from: https://peraturan.bpk. go.id/Details/152511/permenkes-no-12-tahun-2020
Widyanita A, Arini M, Dewi A. Evaluasi Implementasi Clinical Pathway Appendicitis Akut Pada Unit Rawat Inap Bagian Bedah Di RSUD Panembahan Senopati Bantul. Pros Interdiscip Postgrad Student Conf 3 rd. 2016;37–43.
Creswell JW, Hirose M. Mixed methods and survey research in family medicine and community health. Fam Med Community Heal. 2019;7(2):1–6.
Utarini A. Mixed-method Study Referensi Utama : Mater Penelit kualitatif dan Mix. 2018.
Whittle CL, Dunn L, Mcdonald PS, de Luc K. Assessing the content and quality of pathways. Researchgate [Internet]. 2008; Available from: https://www.researchgate.net/publication/237821114_Assessing_the_content_and_quality_of_pathways
Hadira, syahrul S, Rachmawaty R. Efektivitas Penerapan Integrated Clinical Pathway (ICP) Terkait Manajemen Risiko Ter-hadap Kualitas Pelayanan Di Rumah Sakit : Literatur Review. J Keperawatan Muhammadiyah. 2020:97–106.
Angeline WK, Martina M, Girsang E, Nasution AN. Clinical Pathway Implementation in ACS STEMI Patients. J Aisyah J Ilmu Kesehat. 2022;7(3):901–6.
Ayu Fitri D, Sundari S. The Evaluation of Clinical Pathway Implementation on Cerebral Infarction in the Inpatient Care Unit of Bantul X Hospital. J Medicoeticolegal dan Manaj Rumah Sakit. 2018;7(2):152–61.
Kusumah B, Sri S LE. Evaluasi terhadap implementasi dan kepatuhan clinical cathway dengue fever di rumah sakit PKU muhammadiyah gamping yogyakarta. E Clin. 2014;24(3):26–9.
Rizal AA. Hubungan tingkat Pendidikan Perawat InstalasI Gawat Darurat dengan Kepatuhan Pelaksanaan Standar Prosedur Operasional Penerimaan Pasien Baru di RSUD AM Parikesit Tenggarong. J Ilmu Kesehat. 2017;5(1):1–10.
Ambroggio L, Thomson J, Murtagh Kurowski E, Courter J, Statile A, Graham C, et al. Quality improvement methods increase appropriate antibiotic prescribing for childhood pneumonia. Pediatrics. 2013;131(5):e1623-31. doi: 10.1542/peds.2012-2635.
Farhanisa F. Kejadian Efek Samping Obat Anti Tuberkulosis (Oat) Kategori 1 pada Pasien Tb Paru di Unit Pengobatan Penyakit Paru-paru (Up4) Provinsi Kalimantan Barat. J Mhs Farm Fak Kedokt UNTAN. 2015;3(1).
Rachmawati C, Pinzon RT, Lestari T. Evaluasi Implementasi Clinical Pathway Appendicitis Evaluation of Implementation of Clinical Pathway for. Berk Ilm Kedokt Duta Wacana. 2017;2(3):437–44.
Fadilah NFN, Budi SC. Efektifitas Implementasi Clinical Pathway Terhadap Average Length Of Stay dan Outcomes Pasien DF-DHF Anak di RSUD Kota Yogyakarta. J Kesehat Vokasional. 2018;2(2):175.
Riza RC, Nurwahyuni A. The Implementation and Outcome of Clinical Pathway: A Systematic Review. 2019;677–86.
Kusumaningtyas T, Utarini A, Pinzon RT. Dampak Pemberlakuan Clinical Pathway Terhadap Impact of Clinical Pathway Implementation on Quality of. Berk Ilm Kedokt Duta Wacana. 2017;2(2):349–60.
Darer J, Pronovost P, Bass EB. Use and evaluation of critical pathways in hospitals. Eff Clin Pract. 2002;5(3): 114–9.
Perwitasari, Handayani Gurning S, Aryani Perwitasari D. Analisis Biaya Penerapan Clinical Pathway Pada Pasien Sectio Caesarea Di Rsud Sele Be Solu Kota Sorong Cost Analysis of Clinical Pathways in Sectio Caesarea Patients At Sele Be Solu Hospital, Sorong City. Media Farm. 2021;18(1): 13.
Djasri H. Clinical Pathways : Perkenalan Hanevi Djasri dan Clinical Pathways Sistematika Pembahasan. 2022;19(sejak 2009):1–20.
Azisah A. Efektifitas Integrated Clinical Pathway Terhadap Patient Health Outcomes, Length of Stay, Dan Hospital Cost Di Rsud Sayang Rakyat Makassar. Univ Hasanuddin [Internet]. 2019. Available from: http://repository. unhas.ac.id:443/id/eprint/563
Iroth JS, Ahmad RA, Pinzon R et. Dampak Penerapan Clinical Pathway Terhadap Biaya Perawatan Pasien Stroke Iskemik Akut Di Rs Bethesda the Influence of Clinical Pathway Implementation and Cost of Care in Stroke Patients in Bethesda Hospital. Berk Ilm Kedokt Duta Wacana. 2016;02:267–77. doi: https://doi.org/ 10.21460/bikdw.v2i1.38
Iswari A, Endarti D, Trijayanti C, Haris RNH, Imansari ANR. Analisis Biaya Penyakit Tuberkulosis: Studi Kasus di Salah Satu Puskesmas dan Rumah Sakit di Yogyakarta. Maj Farm. 2020; 16(2):211.
KemenKes RI. Pedoman Nasional Pelayanan Kedokteran Tata Laksana Tuberkulosis [Internet]. 2019. Available from: https://yankes.kemkes. go.id/unduhan/fileunduhan_1610422577_801904.pdf